Interestingly, the proportion of PALB2-associated breast cancers displaying mono-allelic PALB2 inactivation was comparable to the one of BRCA1-associated and BRCA2-associated breast cancers from TCGA harboring BRCA1 or BRCA2 mono-allelic inactivation, respectively. This evidence concerns the gene BRCA2 and breast cancer.